Objectives The concern that nonsteroidal anti‐inflammatory drugs (NSAIDs) may precipitate flares of inflammatory bowel disease (IBD) has limited their use in managing musculoskeletal symptoms in this population, but safety data are mixed. Methods This retrospective cohort study included patients with IBD ≥ 18 years of age from Optum's de‐identified ...
Adam S. Mayer +4 more
wiley +1 more source
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric Approach. [PDF]
Alimenti E +11 more
europepmc +1 more source
A Systematic Comparison of Age, Comorbidity and Frailty of Two Defined ICU Populations in the German Helios Hospital Group from 2016–2021 [PDF]
Kristina Hoffmann +6 more
openalex +1 more source
Discordance between patient and physician global assessments in early systemic sclerosis
Objective This study aims to identify factors associated with patient and physician global assessments and discordance between them in systemic sclerosis (SSc). Methods Data from adults with early SSc (< 5 years) from the CONQUER registry were included.
Ellen Romich +35 more
wiley +1 more source
Metformin provides superior neuroprotective potential compared to semaglutide in preventing diabetes-associated Alzheimer's disease via dual actions. [PDF]
Georgiou A, Zanos P, Onisiforou A.
europepmc +1 more source
MON-811 Novel Subclassification Of Low Bone Mass And Its Association With Comorbidities In Korean Older Adults: A Data-driven Cluster Analysis [PDF]
Seunghyun Lee +3 more
openalex +1 more source
Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among rheumatology patients, and their associations with patient factors, patient reported perceived side effects and positive impacts. Methods An online survey (delivered from March to November 2022) was distributed by Alberta Health Services to ...
Susan Zhang +10 more
wiley +1 more source
Impact of Comorbidities on Clinical Outcomes and Quality of Life of Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer Treated With Palbociclib in the POLARIS Study. [PDF]
Tripathy D +17 more
europepmc +1 more source

